CN108635421A - Summer skin abrasion medication - Google Patents

Summer skin abrasion medication Download PDF

Info

Publication number
CN108635421A
CN108635421A CN201810762701.7A CN201810762701A CN108635421A CN 108635421 A CN108635421 A CN 108635421A CN 201810762701 A CN201810762701 A CN 201810762701A CN 108635421 A CN108635421 A CN 108635421A
Authority
CN
China
Prior art keywords
medication
mass parts
kinds
components
skin abrasion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
CN201810762701.7A
Other languages
Chinese (zh)
Inventor
李宝
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201810762701.7A priority Critical patent/CN108635421A/en
Publication of CN108635421A publication Critical patent/CN108635421A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/63Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
    • A61K36/634Forsythia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/53Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/539Scutellaria (skullcap)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/71Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • A61K36/718Coptis (goldthread)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

Summer skin abrasion medication is made after evenly mixing of four kinds of components of following mass parts last absolute ethyl alcohol for being 55 70 with mass parts of pulverizing, and four kinds of components are:Fructus Forsythiae 45 60, radix scutellariae 10 25, borneol 10 15, the coptis 20 25.This drug accelerates the healing at skin injury there are many antimicrobial component, effectively reduces the susceptibility of teleneuron, reduces pruitus sense of discomfort, prevents the automatic scratching of patient.

Description

Summer skin abrasion medication
Technical field
The present invention relates to a kind of drugs being used to treat skin abrasion suitable for summer.
Background technology
Skin abrasion breakage post-processing is improper to be caused to itch at wound, especially cause wound to be sent out after summer perspires Itch, patient involuntary can be gone to grab illing skin with hand, may be caused to infect at skin injury, be unfavorable for the healing in affected part.
Invention content
The purpose of the present invention is to provide a kind of drugs with anesthesia sensory nerve ending effect and antiinflammation, can be with The susceptibility of sensory nerve ending in skin is reduced, reduces itch sense of discomfort in skin, while accelerating Wound healing.
The technical proposal of the invention is realized in this way:Summer skin abrasion medication by following mass parts four kinds of components The last absolute ethyl alcohol for being 55-70 with mass parts of pulverizing is made after evenly mixing, and four kinds of components are:Fructus Forsythiae 45-60, radix scutellariae 10-25, borneol 10-15, coptis 20-25.
This drug has the advantages that:Accelerate the healing at skin injury with a variety of antimicrobial components, effectively reduces The susceptibility of teleneuron reduces pruitus sense of discomfort, prevents the automatic scratching of patient.
Specific implementation mode:
Summer skin abrasion medication is pulverized the last anhydrous second for being 55-70 with mass parts by four kinds of components of following mass parts Alcohol is made after evenly mixing, and four kinds of components are:Fructus Forsythiae 45-60, radix scutellariae 10-25, borneol 10-15, coptis 20-25.
Several preferred embodiments of this drug are given below.
Fructus Forsythiae 45, radix scutellariae 10, borneol 10, the coptis 20, absolute ethyl alcohol 55.
Fructus Forsythiae 52, radix scutellariae 15, borneol 12, the coptis 22, absolute ethyl alcohol 62.
Fructus Forsythiae 60, radix scutellariae 25, borneol 15, the coptis 25, absolute ethyl alcohol 70.
The proportionate relationship of above-mentioned mass parts namely a component.
Application method:This medicament is uniformly smeared at skin injury, 2 times a day.Medication is adjusted according to the case where wound It measures, reduction dosage can be taken the circumstances into consideration at skin injury after improving situation.
The characteristics of introducing each component individually below and control effect and mechanism.
Fructus Forsythiae:Bitter is slightly cold.There are clearing heat and detoxicating, dispersing swelling and dissipating binds.Principle active component is Flavonol glycoside, this product There are powerful antiinflammatory and bacteriostatic functions.
Radix scutellariae:Degerming spectrum is wider, to the corynebacterium diphtheriae of easy infection, tubercle bacillus, comma bacillus, dysentery bar at skin abrasion Bacterium and Candida albicans have inhibiting effect.
Borneol:Acrid flavour, hardship, are slightly cold.Has effects that clearing away heat to and alleviating pain.There is powerful transdermal function, contains L-Borneol, stone The triterpenoids such as half terpene component such as bamboo alkene and pier tartaric acid alphitolic acid, dipterocarpol have certain analgesic, antisepsis, There is inhibition itching-relieving action to a variety of germs.
The coptis:Bitter, it is cold in nature.A variety of alkaloids such as alkali coptisine, worenine are warded off containing small, have antibacterial action, tool There are antipyretic, calm decompression, analgesia and local anaesthesia effect.Anesthetic effect can be played to the nerve endings at skin injury, reduced The stress reaction of body effectively reduces the automatic scratching affected part of patient.

Claims (1)

1. summer skin abrasion medication, it is characterised in that:The medicament is pulverized last by four kinds of components of following mass parts It is made after evenly mixing for the absolute ethyl alcohol of 55-70 with mass parts, four kinds of components are:Fructus Forsythiae 45-60, radix scutellariae 10-25, borneol 10-15, coptis 20-25.
CN201810762701.7A 2018-07-12 2018-07-12 Summer skin abrasion medication Withdrawn CN108635421A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201810762701.7A CN108635421A (en) 2018-07-12 2018-07-12 Summer skin abrasion medication

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201810762701.7A CN108635421A (en) 2018-07-12 2018-07-12 Summer skin abrasion medication

Publications (1)

Publication Number Publication Date
CN108635421A true CN108635421A (en) 2018-10-12

Family

ID=63751013

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201810762701.7A Withdrawn CN108635421A (en) 2018-07-12 2018-07-12 Summer skin abrasion medication

Country Status (1)

Country Link
CN (1) CN108635421A (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101019956A (en) * 2007-03-19 2007-08-22 殷彬 Bedsore treating medicine
CN101336992A (en) * 2008-08-19 2009-01-07 宋俊锋 Traditional Chinese medicine preparation for treating early burn or scald
CN102973800A (en) * 2012-10-31 2013-03-20 河南牧翔动物药业有限公司 Puffball compound coating agent and preparation method thereof

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101019956A (en) * 2007-03-19 2007-08-22 殷彬 Bedsore treating medicine
CN101336992A (en) * 2008-08-19 2009-01-07 宋俊锋 Traditional Chinese medicine preparation for treating early burn or scald
CN102973800A (en) * 2012-10-31 2013-03-20 河南牧翔动物药业有限公司 Puffball compound coating agent and preparation method thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
梁燕等: "三黄油中冰片的含量测定", 《时珍国医国药》 *

Similar Documents

Publication Publication Date Title
GB2475013A (en) Dosages for menstrual suppression, contraception, and hormone replacement therapy, and methods of administrating same
CN101647917A (en) Traditional Chinese medicine externally-applied anaesthetic
WO2006068768A3 (en) Methods and compositions for treating conditions
NZ591525A (en) Methods of treatment of complicated skin and skin structure infections using single doses of oritavancin
NZ617397A (en) Pth-containing therapeutic/prophylactic agent for osteoporosis, characterized in that pth is administered once a week at unit dose of 100 to 200 units
CN101612278B (en) Medicine for external application for treating pyogenic type contaminated wounds
CN108635421A (en) Summer skin abrasion medication
CN104524213A (en) Plaster for treating bronchiectasis
CN101708253B (en) Prickly heat powder
NZ594154A (en) Transdermal administration of buprenorphine for preoperative treatment of post operative pain
CA2756742A1 (en) Composition for prevention or treatment of insomnia
CN104606504A (en) External plaster for treating the gastric ulcer
CN102846884A (en) Analgesia plaster and preparation method thereof
CN101342277B (en) Externally used antimicrobial spray for treating snore and preparation method thereof
CN108524622A (en) A kind of tapon for killing vagina mould
CN101543555A (en) Combined medicine for treating burn and scald
CN100475247C (en) External application medicine for treating vertebrae lumbales hyperosteogeny
CN101647803B (en) External-use medicine for treating burns
CN107281290A (en) A kind of analgesic plaster for alleviating kidney stone pain
CN108514575A (en) Treat the medicament of wind-cold flu
CN100518784C (en) Externally applied medicine of traumatic injury, rheumatic arthralgia
CN101947229A (en) Medicinal composition for treating rhinitis
CN100506239C (en) Chinese traditional medicine preparation for treating herpes zoster and preparing method thereof
CN108607029A (en) The protection cream used after extraction
CN100998604A (en) Traditional Chinese medicine for treat burns and scald and its preparing method

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WW01 Invention patent application withdrawn after publication
WW01 Invention patent application withdrawn after publication

Application publication date: 20181012